Atlas Trials

Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents

Clinical trial NCT02216552 · COMPLETED

Trial details

NCT number
NCT02216552
Sponsor
University of Manitoba
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
NAFLDTYPE 2 DIABETESMETABOLIC SYNDROME
Start date
2015-08-01
Primary completion
2017-01-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.